Course Title

CAR T-Cell Therapy: A Comprehensive Introduction, Clinical Applications, and Potential Complications
CAR T-Cell Therapy: An Overview, Clinical Applications, and Potential Complications

Course Overview

This course offers specialized training aimed at providing participants with a comprehensive understanding of... CAR T-cell therapy As one of the latest and most potent immunotherapies used to treat cancer, the course reviews the treatment's mechanism, its historical development, and the trajectory of its clinical application, in addition to key potential complications such as... Cytokine Release Syndrome (CRS) ...and neurological effects, as well as methods for managing them in accordance with the latest global protocols.

This course is designed to equip healthcare professionals with practical, scientific, and evidence-based knowledge, thereby enhancing their ability to manage patients eligible for treatment and improving the quality of care provided to them.

Course Objectives

General Objectives

• Understanding the fundamentals of CAR T-cell therapy and its role in modern healthcare.

• Understanding the clinical applications of the treatment and the complete process of its administration to patients.

• Enhancing the ability of healthcare practitioners to detect serious complications and manage them effectively.

Detailed Objectives

By the end of the course, participants will be able to:

• identification CAR T-Cell Therapy And he explained his therapeutic philosophy.

• Discussing the historical evolution of treatment and its impact on cancer treatment.

• Analysis of treatment steps, from patient selection to post-infusion follow-up.

• Identifying the most significant complications, such as CRS and Neurotoxicity.

• Applying scientific principles to assess complications and initiate appropriate treatment early.

• Understanding modern standards for managing side effects in accordance with global protocols.

Target audience

• Physicians across all specialties, particularly in oncology, internal medicine, emergency medicine, and intensive care.

• Nursing staff in oncology and intensive care units.

• Professionals working in laboratories, stem cells, and advanced therapies.

• Any healthcare practitioner interested in understanding the latest advanced immunotherapies.

Expected outputs

By the end of the course, the trainee will be able to:

• An explanation of the principles of CAR T-cell immunotherapy.

• Determining the correct clinical treatment pathway from A to Z.

• Recognizing high-risk treatment complications and rapid intervention methods.

• Implementation of CRS and neurotoxicity assessment protocols.

• Supporting patients through a better understanding of treatment stages and potential risks.

The course is accredited by:

1- Higher Health Council – 1.5 CPD – Accreditation No. HHC-ROOT-E-CPD1048-6-26
2- Jordanian Nursing Council – 1.5 CPD – Accreditation No. 765/27 (Valid until July 2026)